- Bayer (BAYZF) has offered 14.76B Norwegian kroner ($2.41B) to acquire partner Algeta (ALGZF), with the bid of 336 kroner a share representing a 27% premium to the latter's last closing price.
- Earlier this month, Bayer and Algeta received EU marketing approval for prostate-cancer treatment Xofigo. (PR)
This was corrected on 11/26/2013 at 06:51 AM.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs